BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16675154)

  • 1. Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete.
    MacDonald AB
    Med Hypotheses; 2006; 67(3):592-600. PubMed ID: 16675154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
    Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
    Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
    MacDonald AB
    Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
    D'Andrea MR; Nagele RG
    Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of single Alzheimer solid plaque cores by laser capture microscopy and nanoelectrospray/tandem mass spectrometry.
    Söderberg L; Bogdanovic N; Axelsson B; Winblad B; Näslund J; Tjernberg LO
    Biochemistry; 2006 Aug; 45(32):9849-56. PubMed ID: 16893185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reconstruction of the three-dimensional structure of senile plaques in Alzheimer disease].
    Ye W; Zhou JN; Hu XY; Liu JW; He JH; Tang XW
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):449-53. PubMed ID: 12766806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages.
    Stone J
    Med Hypotheses; 2008 Sep; 71(3):347-59. PubMed ID: 18524497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin.
    Gellermann GP; Ullrich K; Tannert A; Unger C; Habicht G; Sauter SR; Hortschansky P; Horn U; Möllmann U; Decker M; Lehmann J; Fändrich M
    J Mol Biol; 2006 Jul; 360(2):251-7. PubMed ID: 16765377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
    D'Andrea MR; Nagele RG
    Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of amyloid plaque pathogenesis.
    Fiala JC
    Acta Neuropathol; 2007 Dec; 114(6):551-71. PubMed ID: 17805553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain.
    Wilcock DM; Gordon MN; Morgan D
    Nat Protoc; 2006; 1(3):1591-5. PubMed ID: 17406451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.